Market Data graphic

Life Sciences

You are here

The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.

Life sciences companies listed on CSE

BC Craft Supply Co Ltd (CSE:CRFT) is a diversified life sciences company advancing cannabinoid and psychedelic innovation and psychotherapy.  The Company offers a reimagined vision for craft markets through collaboration, expertise, and adaptation. 

It’s operations include CRFT - a curator and aggregator of craft cannabis, providing advocacy and access for premium small-batch growers to Canada’s cannabis market; Medcann Health Products - a cultivation and processing facility in Chemainus providing access to both Canadian medical and recreational cannabis markets; Feelwell Brands - a successful cannabinoid brand house licensed in the state of California; and AVA Pathways - a pre-clinical biotech company focused on neuroplasticity and mental health applications using psilocybin and compounds derived from mushrooms.

The Issuer is an United States multi-state cannabis CPG company that reaches over 113 million Americans across California, Colorado, Florida, Illinois, Maryland, Nevada, Michigan and Oklahoma, with a portfolio of cannabis brands.

Better Plant makes and sells over 40 products, all made with 100% natural ingredients, under the brands Jusu and NeonMind. Through its Shopify enabled eCommerce site getjusu.com, Better Plant sells plant-based personal care products and cleaning products. Better Plant products are sold through a network of online and brick and mortar retail locations. Better Plant also offers operational, financial, and other services to companies with businesses that align with Better Plant’s mission to help create a better world.

BetterLife Pharma Inc. ("BetterLife") is an emerging biotechnology company primarily focused on developing and commercializing two compounds, TD-0148A and TD-010, to treat neurological disorders such as depression, cluster headaches and anxiety. TD-0148A is a non-hallucinogenic and non-controlled psychedelic candidate and is unique in that it is not regulated and therefore can be self-administered. TD-010 is a treatment of anxiety without the addictive potential of benzodiazepines. BetterLife also owns a drug candidate for the treatment of viral infections such as COVID-19 and is in the process of seeking strategic alternatives for further development.

BevCanna Enterprises Inc. seeks to develop and manufacture cannabinoid-infused beverages and consumer products for in-house brands and white label clients. With decades of experience creating, branding and distributing iconic brands that have resonated with consumers on a global scale, the team demonstrates an expertise unmatched in the emerging cannabis beverage category. Based in British Columbia, Canada, BevCanna has a 100-acre outdoor cultivation site in the fertile Okanagan Valley and the exclusive rights to a pristine spring water aquifer, as well as a world-class 40,000-square-foot, HACCP certified manufacturing facility, with a current bottling capacity of up to 72M bottles. BevCanna’s vision is to be the global leader infused innovations.

Make the fairly enjoyable ridiculously fun! For over a decade, Bhang has delivered exceptional sensory experiences to consumers through its extensive portfolio of over 50 master-chef created cannabis, CBD, and terpene products including highly-awarded gourmet chocolates, pre-rolls, CBD isolate, and Hempsticks™. Bhang’s gourmet, cannabis-infused chocolates are among the top-selling edibles in 7 U.S. states and Canada. Bhang’s CBD products are globally-distributed and known for being safe, efficacious and delicious. 

Investor Note: In addition to the 107,358,457 Subordinate Voting Shares that are listed and trading, there are 47,292,501 Subordinate Voting Shares reserved for issuance pursuant to the conversion rights attached to other classes of equity shares that are issued and outstanding but not listed. The total number of issued shares assuming all equity shares are converted into the listed class would be 154,650,958.

 

Biocure Technology Inc. is a biopharmaceutical company, specializing in the development and commercialization of major biosimilar products. Biocure is currently conducting pre-clinical trials of its biosimilar candidates of Interferon Beta 1b, PEG-Filgrastim and Ranibizumab as well as CAR-T Cell Therapy.

BioHarvest Sciences has developed a patented bio-cell growth platform technology capable of growing the active and beneficial ingredients in fruit and plants, at industrial scale, without the need to grow the plant itself. This technology is economical, ensures consistency, and avoids the negative environmental impacts associated with traditional agriculture. BioHarvest is currently focused on nutraceuticals and the medicinal cannabis markets.

BioMark is a Canadian based company that is developing its advanced stage cancer diagnostic business. BioMark’s cancer diagnostics technology platform leverages "Omics" and machine learning which allows for early cancer detection. BioMark is currently focused on bringing its cancer diagnostic kits and detection solution to commercialization standards and hopes to commence distribution once clinical trials are complete and regulatory acceptance is obtained. For more information please visit the company’s website at www.biomarkdiagnostics.com

Biome Grow Inc. (CSE:BIO) is a Canadian cannabis company with operations mainly concentrated in Atlantic Canada.   The company wholly owns five subsidiaries, including: The Back Home Medical Cannabis Corporation, a company incorporated under the laws of the Province of Newfoundland and Labrador and in the late stages of applying for a license under the Cannabis Act; Great Lakes Cannabis, an Ontario company also in the late stages of applying for a license; Highland Grow Inc., a licensed producer in Nova Scotia; Red Sands Craft Cannabis Co., a Prince Edward Island company set up to provide extraction services; and Weed Virtual Retail Inc., an Ontario company in the business of operating a new virtual reality technology and education platform.  In addition to these domestic cultivation and distribution assets, Biome also has five retail licenses in Newfoundland with stores opening this year as well as a significant MOU to be supplied a large quantity of CBD from a third-party supplier.  The company hopes to leverage the CBD business both at home and abroad by producing and exporting a range of CBD infused products starting late 2019.

Contact The Team

How can we help you?

Contact the CSE team to find out more.

Advertisement

Publicité

Latest CSE News

Upcoming Events

2022-01-25-Jamaica-Stock-Exchange-Conference_Website.png

17th Regional Investments & Capital Markets Conference 2022

Tuesday, January 25, 2022 to Thursday, January 27, 2022

Advertisement

Publicité